Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents. 2016

Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China.

A novel series of substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methylquinazolin-4-amines were synthesized and evaluated for their in vitro antiproliferative activity. Among them, compound 7a exhibited the best potency, with IC50 values of 0.029-0.147 μM against four types of cancer cell lines. In addition, 7a was confirmed that it could arrest the cell cycle at G2/M phase and trigger apoptosis. Indirect immunofluorescence staining revealed its anti-tubulin property. Importantly, 7a significantly inhibited tumor growths in HepG2 xenograft models without causing significant loss of body weight, suggesting that 7a is a promising new anticancer agent to be developed.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
January 2004, Bioorganic & medicinal chemistry letters,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
February 2010, Archiv der Pharmazie,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
January 2017, Central nervous system agents in medicinal chemistry,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
February 2016, European journal of medicinal chemistry,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
September 1983, Archiv der Pharmazie,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
August 2013, Medicinal chemistry (Shariqah (United Arab Emirates)),
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
October 2014, Acta crystallographica. Section E, Structure reports online,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
February 2020, Bioorganic & medicinal chemistry letters,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
October 2022, ACS pharmacology & translational science,
Dong Cao, and Xiaoyan Wang, and Lei Lei, and Liang Ma, and Fang Wang, and Chunyu Wang, and Minghai Tang, and Wei Xiang, and Taijin Wang, and Hongyang Li, and Lijuan Chen
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
Copied contents to your clipboard!